Simple Blood Test to Detect Cancer Early and Save Lives

PrognomIQ is a diagnostics company developing simple blood tests for early detection of cancer. As a spin out company from Seer, an aMoon Growth Portfolio company, PrognomiQ leverages Seer's technology for unbiased proteomic analysis at unprecedented depth, breadth, and speed.

PrognomIQ combines this unique capability for proteomic analysis with genomics and other omics data, to develop and commercialize multi-omics tests for cancer.